Related references
Note: Only part of the references are listed.Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C
Anna S. Lok et al.
GASTROENTEROLOGY (2011)
Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma
Soji Shimomura et al.
HEPATOLOGY INTERNATIONAL (2011)
Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009
Osamu Yokosuka et al.
HEPATOLOGY RESEARCH (2011)
Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials
Chuan-Hai Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
Hiroaki Hagihara et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma
A. K. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection
Yasuhiro Asahina et al.
HEPATOLOGY (2010)
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
Hiromitsu Kumada et al.
HEPATOLOGY RESEARCH (2010)
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
Hiromitsu Kumada et al.
HEPATOLOGY RESEARCH (2010)
Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
Masayuki Kurosaki et al.
HEPATOLOGY RESEARCH (2010)
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer
Kenji Ikeda et al.
HEPATOLOGY RESEARCH (2010)
Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Izumi Namiki et al.
HEPATOLOGY RESEARCH (2010)
Report of the 18th follow-up survey of primary liver cancer in Japan
Iwao Ikai et al.
HEPATOLOGY RESEARCH (2010)
High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients
Srunthron Akkarathamrongsin et al.
HEPATOLOGY RESEARCH (2010)
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
Ying-Chun Shen et al.
JOURNAL OF HEPATOLOGY (2010)
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
Ana-Carolina Cardoso et al.
JOURNAL OF HEPATOLOGY (2010)
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok et al.
GASTROENTEROLOGY (2009)
The Natural History of Chronic Hepatitis B Virus Infection
Brian J. McMahon
HEPATOLOGY (2009)
Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
Mika Kurokawa et al.
HEPATOLOGY RESEARCH (2009)
Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: A meta-analysis of randomized controlled trials
Chuan-Hai Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Yasuhiro Miyake et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia
Yun-Fan Liaw
JOURNAL OF HEPATOLOGY (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
J. J. Y. Sung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years
Masaaki Mizui et al.
HEPATOLOGY RESEARCH (2007)
Effects of a 24-week course of interferon-a therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma
Soo Cheol Jeong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma
Soocheol Jeong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Chemoprevention of liver carcinogenesis with retinoids: Basic and clinical aspects
Hisataka Moriwaki et al.
HEPATOLOGY RESEARCH (2007)
Epidemiology of hepatocellular carcinoma in USA
Hashem B. El-Serag
HEPATOLOGY RESEARCH (2007)
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis
Erik H. C. J. Buster et al.
HEPATOLOGY (2007)
Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study
Hideyuki Nomura et al.
HEPATOLOGY RESEARCH (2007)
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma
Chung Mau Lo et al.
ANNALS OF SURGERY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis:: A randomized trial
Laetitia Fartoux et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
Shi-Ming Lin et al.
JOURNAL OF HEPATOLOGY (2007)
Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation
Masatoshi Kudo et al.
ONCOLOGY (2007)
Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis
Takashi Someya et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
Vincenzo Mazzaferro et al.
HEPATOLOGY (2006)
Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma
Takahiro Uenishi et al.
HEPATOLOGY RESEARCH (2006)
Growth inhibitory effects of pegylated IFN α-2b on human liver cancer cells in vitro and in vivo
Hirohisa Yano et al.
LIVER INTERNATIONAL (2006)
Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:: a randomized clinical trial
Hui-Chuan Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP
S Murashima et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Antiviral therapy for chronic hepatitis C: past, present, and future
N Hayashi et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus
CH Hung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients
A Matsumoto et al.
HEPATOLOGY RESEARCH (2005)
Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma
Y Sakaguchi et al.
INTERVIROLOGY (2005)
Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma
S Nishiguchi et al.
INTERVIROLOGY (2005)
Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a Large-scale long-term study in a single center
K Ikeda et al.
INTERVIROLOGY (2005)
Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors
SM Lin et al.
CANCER (2004)
Hepatocellular carcinoma: Recent trends in Japan
K Kiyosawa et al.
GASTROENTEROLOGY (2004)
Interferon-αCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo
T Hisaka et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
K Ohata et al.
CANCER (2003)
Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy
P Lampertico et al.
HEPATOLOGY (2003)
Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2003)
Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy
S Kubo et al.
BRITISH JOURNAL OF SURGERY (2002)
Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications
MF Yuen et al.
HEPATOLOGY (2001)
Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study
T Suou et al.
HEPATOLOGY RESEARCH (2001)
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis
A Gramenzi et al.
GUT (2001)
Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma -: A randomized, controlled trial
S Kubo et al.
ANNALS OF INTERNAL MEDICINE (2001)
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis:: an evidence-based approach
C Cammà et al.
JOURNAL OF HEPATOLOGY (2001)
The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B
GV Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2001)
Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
S Nishiguchi et al.
LANCET (2001)
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer
K Ikeda et al.
HEPATOLOGY (2000)
High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential
L Wang et al.
HEPATOLOGY (2000)
Share Paper
